Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
adverse event reporting
Pharma
ASH: Study digs into FDA adverse event record of BCMA therapies
As the FDA looks into existing CAR-T therapies' secondary cancer risk, a new study examined adverse event reports for three BCMA immunotherapies.
Angus Liu
Dec 11, 2023 2:46am
3 more deaths among Aduhelm patients add to safety concerns
Feb 16, 2022 6:35pm
Was Aduhelm to blame in the recent death of an AD patient?
Nov 18, 2021 2:56pm
Biogen's Aduhelm records one patient death. Is it to blame?
Nov 9, 2021 11:27am
AbbVie mishandles Humira death complaints: FDA
Jun 11, 2018 1:38pm
Regeneron’s Eylea sees upward tick in side-effect cases
Feb 22, 2018 10:08am